跳到正文
openFDA 已分级药品召回执法报告·· 12 天前AI 评分45

FDA药品执法报告D-0143-2027:Victory Medical Center Pharmacy因加工控制缺失召回TESAMORELIN

FDA drug enforcement D-0143-2027: Victory Medical Center Pharmacy — Lack of Processing Controls

AI 导读

FDA发布药品执法报告D-0143-2027,Victory Medical Center Pharmacy(德州奥斯汀)因加工控制缺失自愿召回TESAMORELIN(MDV)10MG/ML 3ML,涉及批次2032646(有效期2026年11月2日),共90瓶,分销至CO、FL、TX,分类为Class II,状态持续中。报告日期为2026年11月11日,召回启动日为2026年10月19日。

正文 · 原文

FDA drug recall enforcement report — D-0143-2027

Report issued: 2026-11-11. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "4303 Victory Dr",

"address_2": "",

"center_classification_date": "20261030",

"city": "Austin",

"classification": "Class II",

"code_info": "Lot, expiry: Lot 2032646 , exp 11/2/2026",

"country": "United States",

"distribution_pattern": "CO, FL, TX",

"event_id": "100168",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {},

"postal_code": "78704-7507",

"product_description": "TESAMORELIN (MDV) 10MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas",

"product_quantity": "90 vials",

"product_type": "Drugs",

"reason_for_recall": "Lack of Processing Controls",

"recall_initiation_date": "20261019",

"recall_number": "D-0143-2027",

"recalling_firm": "Victory Medical Center Pharmacy",

"report_date": "20261111",

"state": "TX",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov